Valproic acid may also disrupt the balance of the hypothalamic-pituitary-ovarian (HPO) axis by affecting the secretion of gonadotropin-releasing hormone (GnRH), potentially leading to PCOS or other reproductive endocrine disorders in women (26). The gene discussed is GNRH1; the disease is polycystic ovary syndrome.